These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 9208668)

  • 1. [Diagnosis and course (under treatment) of Parkinson disease].
    Fénelon G
    Rev Prat; 1997 May; 47(10):1062-7. PubMed ID: 9208668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Diagnosis and therapy of Parkinson's disease].
    Wittstock M; Benecke R
    MMW Fortschr Med; 2005 May; 147 Spec No 2():28-31. PubMed ID: 15968869
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Parkinson "plus"].
    Fabre N; Brefel-Courbon C; Rascol O
    Rev Prat; 1997 May; 47(10):1077-82. PubMed ID: 9208670
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of advanced Parkinson's disease.
    Diamond A; Jankovic J
    Expert Rev Neurother; 2006 Aug; 6(8):1181-97. PubMed ID: 16893346
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Motor symptoms in Parkinson disease].
    Larsen JP; Beiske AG; Bekkelund SI; Dietrichs E; Tysnes OB; Vilming ST; Aasly JO
    Tidsskr Nor Laegeforen; 2008 Sep; 128(18):2068-71. PubMed ID: 18846123
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Drug treatment is beneficial also for elderly patients with Parkinson disease. Important to consider also other co-existing diseases].
    Granérus AK
    Lakartidningen; 2001 Mar; 98(13):1515-23. PubMed ID: 11330147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Hallucinations in Parkinson's disease].
    Moser A; Hagenah J; Kömpf D
    Nervenarzt; 2003 Apr; 74(4):376-85, quiz 385-6. PubMed ID: 12707709
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Diagnosis and treatment of tremor in Parkinson's disease and essential tremor].
    Wolters A; Benecke R
    MMW Fortschr Med; 2007 May; 149 Suppl 2():94-6. PubMed ID: 17724978
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Parkinson's disease: clinical features.
    Quinn NP
    Baillieres Clin Neurol; 1997 Apr; 6(1):1-13. PubMed ID: 9426865
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Objective assessment in Parkinson's disease: optoelectronic movement and force analysis in clinical routine and research.
    Ingvarsson PE; Johnels B; Steg G; Olsson T
    Adv Neurol; 1999; 80():447-58. PubMed ID: 10410755
    [No Abstract]   [Full Text] [Related]  

  • 11. [Improvements in motor and non-motor symptoms in parkinson patients under ropinirole therapy].
    Buchwald B; Angersbach D; Jost WH
    Fortschr Neurol Psychiatr; 2007 Apr; 75(4):236-41. PubMed ID: 17427044
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The 'magic' of L-dopa: why is it the gold standard Parkinson's disease therapy?
    Mercuri NB; Bernardi G
    Trends Pharmacol Sci; 2005 Jul; 26(7):341-4. PubMed ID: 15936832
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of deep brain stimulation and L-Dopa on electrocortical rhythms related to movement in Parkinson's disease.
    Devos D; Defebvre L
    Prog Brain Res; 2006; 159():331-49. PubMed ID: 17071241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Levodopa and cognitive disorders in Parkinson's disease].
    Leiva-Santana C; Alvarez-Saúco M
    Rev Neurol; 2006 Jul 16-31; 43(2):95-100. PubMed ID: 16838257
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Neuroleptic-induced parkinsonism and Parkinson's disease: differential diagnosis and treatment.
    Hausner RS
    J Clin Psychiatry; 1983 Jan; 44(1):13-6. PubMed ID: 6130081
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Young-onset Parkinson's disease revisited--clinical features, natural history, and mortality.
    Schrag A; Ben-Shlomo Y; Brown R; Marsden CD; Quinn N
    Mov Disord; 1998 Nov; 13(6):885-94. PubMed ID: 9827611
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dopaminergic modulation of cognitive function-implications for L-DOPA treatment in Parkinson's disease.
    Cools R
    Neurosci Biobehav Rev; 2006; 30(1):1-23. PubMed ID: 15935475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glottographic measures before and after levodopa treatment in Parkinson's disease.
    Jiang J; Lin E; Wang J; Hanson DG
    Laryngoscope; 1999 Aug; 109(8):1287-94. PubMed ID: 10443835
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Clinical aspects and conservative therapy of Parkinson disease].
    Dengler R
    Zentralbl Neurochir; 1995; 56(4):148-52. PubMed ID: 8571692
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical subtypes of Parkinson disease].
    Poewe W; Gerstenbrand F
    Wien Med Wochenschr; 1986 Aug; 136(15-16):384-7. PubMed ID: 3788189
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.